Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients
Status:
Not yet recruiting
Trial end date:
2024-06-20
Target enrollment:
Participant gender:
Summary
This is a multi-center, prospective, double-blind randomized controlled trial on a sample of
patients with migraine. Subjects will only be enrolled when a physician or research assistant
who is familiar with the study protocol is available to enroll patients. Written, informed
consent will be obtained from each patient. Consent will include a discussion of the risks
and benefits.